Press release
Targeted Therapeutics Market Size is Expected to Reach USD 118.6 Billion, Rising at a CAGR of 6.4% by 2031 | TMR Research
Targeted Therapeutics Market
Targeted Therapeutics Market (타겟 치료제 시장) is expected to grow at a CAGR of 6.4% from 2023 to 2031 and reach US$ 118.6 Bn by the end of 2031
Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=51390
Overview of Targeted Therapeutics Market
The global targeted therapeutics market is expanding rapidly due to the increasing prevalence of chronic diseases, advancements in biotechnology, and a growing focus on personalized medicine. The market is segmented by therapeutic area (oncology, immunology, cardiovascular diseases, others), type of therapy (monoclonal antibodies, small molecules, others), end-users (hospitals, specialty clinics, research institutes), and geographical regions.
Top Companies:
Sanofi
GlaxoSmithKline plc
Takeda Pharmaceutical Company Ltd.
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
AstraZeneca
Seagen, Inc.
Bayer AG
Amgen, Inc.
Bristol-Myers Squibb Company
Recent Developments in Targeted Therapeutics Market
Recent advancements and trends in the targeted therapeutics market include:
Precision Medicine: Growing adoption of precision medicine approaches that tailor treatments based on individual genetic, environmental, and lifestyle factors.
Next-Generation Biologics: Development of next-generation biologics, including bispecific antibodies and antibody-drug conjugates (ADCs), offering enhanced specificity and potency.
Immunotherapy Advances: Significant progress in immunotherapies, such as checkpoint inhibitors and CAR-T cell therapies, showing promising results in treating various cancers.
Molecular Diagnostics: Integration of advanced molecular diagnostics to identify specific biomarkers and guide the selection of targeted therapies.
Combination Therapies: Increasing use of combination therapies that pair targeted agents with other treatments, such as chemotherapy or radiation, to improve outcomes.
Drivers of Market Growth
Several factors contribute to the growth of the targeted therapeutics market:
Rising Prevalence of Chronic Diseases: Increasing incidence of chronic diseases, particularly cancer, driving demand for effective and specific treatments.
Advancements in Biotechnology: Continuous advancements in biotechnology facilitating the development of novel targeted therapies with improved efficacy and safety profiles.
Personalized Medicine: Growing focus on personalized medicine approaches that customize treatments based on individual patient characteristics and disease profiles.
Regulatory Approvals: Supportive regulatory frameworks and expedited approval processes for innovative targeted therapies accelerating market growth.
Healthcare Infrastructure: Improved healthcare infrastructure and access to advanced treatment options in emerging markets promoting the adoption of targeted therapeutics.
Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=51390
Conclusion
The targeted therapeutics market is poised for significant growth, driven by the rising prevalence of chronic diseases, advancements in biotechnology, personalized medicine approaches, regulatory support, and improved healthcare infrastructure. Innovations in precision medicine, next-generation biologics, immunotherapy advances, molecular diagnostics, and combination therapies are enhancing the potential and efficacy of targeted treatments.
Market Segmentation
Type
Monoclonal Antibodies (Angiogenesis Inhibitors, HER-2 Targeted Agents, and Anti-CD20 Monoclonal Antibodies)
Small Molecule (Tyrosine Kinase Inhibitors)
Application
Breast Cancer
Colorectal Cancer
Leukemia
Lung Cancer
Lymphoma
Multiple Sclerosis
Renal Cancer
Wet Age-related Macular Degeneration
Others (Ovarian Cancer, Fallopian Tube Cancer, Prostate Cancer, and Pancreatic Cancer)
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions Covered
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=51390<ype=S
More Trending Reports by Transparency Market Research -
Urinary Tract Disorders Propels Ureteral Stents Market (尿路疾患が尿管ステント市場を牽引): https://www.globenewswire.com/news-release/2024/07/05/2909009/32656/en/Rising-Incidence-of-Urinary-Tract-Disorders-Propels-Ureteral-Stents-Market-to-Achieve-USD-823-7-Million-by-2031-Transparency-Market-Research-Inc.html
Cryotherapy Market (Marché de la cryothérapie): https://www.globenewswire.com/en/news-release/2024/07/03/2908096/32656/en/Cryotherapy-Market-to-be-Worth-USD-885-7-million-by-2034-Growing-a-CAGR-9-3-Exclusive-Report-by-Transparency-Market-Research-Inc.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Targeted Therapeutics Market Size is Expected to Reach USD 118.6 Billion, Rising at a CAGR of 6.4% by 2031 | TMR Research here
News-ID: 3603848 • Views: …
More Releases from Transparency Market Research
Global Controlled Substance Market Poised to Reach USD 169.8 Billion by 2035 at …
The global controlled substance market is undergoing a period of significant transformation, fueled by rising chronic disease burdens, scientific innovation, evolving regulatory frameworks, and growing adoption of advanced treatment protocols. Controlled substances-ranging from opioids, stimulants, and depressants to certain cannabinoids-play a crucial role in managing chronic pain, neurological disorders, psychiatric conditions, and several forms of cancer. As the demand for effective and safe therapeutic options rises, the industry is witnessing…
Polymer and Resin Market Set to Reach US$ 998.4 Billion by 2035, Driven by Autom …
The global Polymer and Resin Market is entering a transformative decade marked by strong industrial demand, sustainability-driven innovations, and accelerated applications across automotive, packaging, construction, electronics, and healthcare sectors. According to the latest market assessment, the global polymer and resin market, valued at US$ 576.3 billion in 2024, is forecast to reach US$ 998.4 billion by 2035, expanding at a CAGR of 5.2% from 2025 to 2035.
With Asia Pacific accounting…
Global Beauty Devices Market to Reach USD 99.87 Billion by 2035, Driven by Surge …
The global beauty devices market is entering a transformative era as consumers increasingly prioritize self-care, personal grooming, and tech-driven beauty solutions. According to the latest industry analysis, the beauty devices market, valued at US$ 36,188.7 Mn in 2024, is projected to reach US$ 99,873.0 Mn by 2035, reflecting a robust CAGR of 9.7% between 2025 and 2035. Fueled by rising digital beauty trends, the growing popularity of non-invasive treatments, and…
Global Aesthetic Threads Market Poised to Reach USD 294.0 Million by 2035, Drive …
The global aesthetic threads market is entering a new phase of accelerated expansion, driven by rising consumer demand for minimally invasive cosmetic procedures, continuous product innovation, and a rapidly expanding network of aesthetic clinics worldwide. According to recent industry analysis, the market was valued at US$ 149.2 million in 2024 and is projected to reach US$ 294.0 million by 2035, exhibiting a steady CAGR of 6.4% between 2025 and 2035.…
More Releases for Targeted
Targeted Alpha Therapy Market
Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights:
• Global Targeted Alpha Therapy Market Insight By Region
• Approved Targeted Alpha Therapy Dosage & Pricing Insight
• Number Of Targeted Alpha Therapy In Clinical Trials: > 20 Drugs
• Targeted Alpha Therapy Clinical Trials Insight By Company, Country, Indication & Phase
• Marketed Targeted Alpha Therapy Clinical Insight By Company, Country & Indication
• Targeted Alpha Therapy Proprietary Technology Platform Insights By…
Dark Truth Behind Targeted Violence
Intimidation and cyberbullying public bullying the (target)victims selected into committing the violent criminal acts if the victims mentality was broken.
The perpetrators are small fraud groups organizing misinformation with false profiles for the public to participate with public bullying while the groups stalk the victim.
San Diego California 2021-2024 plot failed federal agents on standby monitoring the targets failed at there duties of integrity while presidential elections push towards Nov 5 San…
Bispecific Antibodies: Revolutionizing Targeted Cancer Therapy
Bispecific antibodies (BsAbs) are revolutionizing targeted cancer therapy by offering a dual-targeting approach that enhances therapeutic efficacy and addresses tumor heterogeneity. These engineered antibodies are designed to recognize and bind two different antigens simultaneously, providing a more comprehensive attack on cancer cells and improving treatment outcomes.
One of the most successful examples of BsAbs is blinatumomab, which targets CD19 on B-cells and CD3 on T-cells. Blinatumomab has shown remarkable efficacy in…
Targeted Email Leads: Pioneering a New Era in Email Marketing with High-Quality, …
GREENSBORO, NC - 15 August 2024 - In the rapidly evolving digital landscape, one company is setting new standards in email marketing. Targeted Email Leads, a trailblazer in the provision of precision-targeted email lists, is offering meticulously cleaned and verified lists that cater to a wide range of applications, from B2B communications to consumer engagement and interest groups.
What sets Targeted Email Leads apart is their rigorous verification process. Each…
Tetravalent Antibody as Cancer Targeted Therapy
The advent of tetravalent antibodies marks a significant breakthrough in cancer targeted therapy, offering a sophisticated approach to tackling the complex and heterogeneous nature of tumors. These antibodies, engineered to bind to four distinct antigens or epitopes simultaneously, provide enhanced specificity and efficacy, addressing the limitations of traditional monoclonal and even bispecific antibodies.
Download Bispecific, Trispecific and Tetraspecific Antibodies Report:
https://www.kuickresearch.com/ccformF.php?t=1721642510
Cancer is a multifaceted disease characterized by diverse cell populations within a…
Targeted Advertising Solutions Market - Rising Demand from the Providers of Targ …
The rising popularity of digital channels such as mobile and online for media and entertainment, and communications, coupled with their capability to identify and benefit from tracking customer behavior accurately, have created major interest and increasing investments by advertisers on targeted advertising.
Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=47862
Organizations making an entry into the advertising value network need to effectively educate, engage, and create alertness to the advantages of targeted…
